Multiple Myeloma WisdomCard &trade;

A New Drug Used by 71-Year-Old Marathoner Don Wright Could Soon Be Approved to Help More Patients with Multiple Myeloma Says Tackle Cancer Foundation - Yahoo! Finance

finance.yahoo.com — “From Yahoo! Finance: Leaders of the Tackle Cancer Foundation today said they are excited to learn that a new drug for patients with multiple myeloma, pomalidomide from CELGENE, has been submitted to the Food and Drug Administration.” View full resource at finance.yahoo.com

Most Recently Shared on April 30, 2012 at 1:22 pm By:

Bone Cancer OW OW Health

A New Drug Used by 71-Year-Old Marathoner Don Wright Could Soon Be Approved to Help More Patients with Multiple ... http://t.co/9KKklv7A

4 weeks ago...

Donna Regen Patient Advocate

Multiple Myeloma Awareness Bracelet by sweetpea321 on Etsy

etsy.com — “Wrap your wrist in support of multiple myeloma awareness with this beautiful hand-crafted fine Austrian crystal and sterling silver bracelet. This” View full resource at etsy.com

Most Recently Shared on April 12, 2012 at 5:23 am By:

Multiple Myeloma Awareness Bracelet by sweetpea321 http://t.co/rwKdIxgs via @Etsy

1 month ago...

Multiple Myeloma: International Myeloma Foundation

myeloma.org — “Multiple Myeloma: International Myeloma Foundation” View full resource at myeloma.org

Most Recently Shared on March 26, 2012 at 1:01 pm By:

Novartis Pharma

Did you know multiple #myeloma is more prevalent in the US in African Americans than Caucasians? Get informed. Visit http://t.co/RMdPpFLd

Lenalidomide Improves Outcomes in Asymptomatic High-Risk Smoldering and Newly Diagnosed Myeloma

onclive.com — “Continuous treatment with lenalidomide given early prolonged the time to progression, compared with no treatment in patients with high-risk, asymptomatic, smoldering, multiple myeloma.” View full resource at onclive.com

Most Recently Shared on March 23, 2012 at 8:48 pm By:

Editor Oncology

Early, continuous treatment with Revlimid prolonged the time to progression in patients with smoldering #myeloma http://t.co/2C5Cn060

Oncology News - Prognostic significance of serum cystatin C in multiple myeloma |3990468

mdlinx.com — “Oncology Medical Article: Prognostic significance of serum cystatin C in multiple myeloma” View full resource at mdlinx.com

Most Recently Shared on March 23, 2012 at 7:13 am By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

Prognostic significance of serum cystatin C in multiple myeloma: International Journal of Hematology http://t.co/COP93FTI #oncology

Physician Relations Health Organization

Risk of subsequent primary cancer among pr... [Eur J Cancer Prev. 2012] - PubMed - NCBI

ncbi.nlm.nih.gov — “PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.” View full resource at ncbi.nlm.nih.gov

Most Recently Shared on March 22, 2012 at 8:26 pm By:

RT @Myeloma_Doc Patients with prostate cancer have increased risk of second malignancies, including multiple #myeloma http://t.co/I7MOIMdu

Addition of Vorinostat to Bortezomib Achieves Modest Improvement in Progression-Free Survival in Relapsed/Refractory Multiple Myeloma

onclive.com — “Vorinostat added to bortezomib improved progression-free survival compared with bortezomib plus placebo in patients with relapsed/refractory multiple myeloma.” View full resource at onclive.com

Most Recently Shared on March 20, 2012 at 2:13 pm By:

Editor Oncology

Addition of Vorinostat to Bortezomib Achieves Modest Improvement in PFS for Relapsed/Refractory Multiple Myeloma http://t.co/TVDwPrdN

Bob Finn - Medical News Net Health News

Study: Myeloma Survival Gains, but QOL Slides : IMNG Oncology Report

oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com

Most Recently Shared on March 19, 2012 at 6:39 pm By:

Patients with multiple myeloma can live longer, but their quality of life suffers, study says. http://t.co/50XpzIEw

Oncology Medical Article | Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma

mdlinx.com — “Oncology Medical Article: Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma” View full resource at mdlinx.com

Most Recently Shared on March 13, 2012 at 9:22 am By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma... http://t.co/EUGSk1gi #oncology

Early Versus Delayed Autologous Transplantation After Immunomodulatory Agents-Based Induction Therapy in Patients With Newly Diagnosed Multiple Myeloma - OncologySTAT

oncologystat.com — “2012 Mar 1;118(6):1585-1592 - SK Kumar, MQ Lacy, A Dispenzieri, MA Gertz, et al” View full resource at oncologystat.com

Most Recently Shared on March 8, 2012 at 4:09 pm By:

OncologySTAT Health Site and Oncology

Story of the Week: Early or Delayed, Auto-SCT Delivers Comparable Survival in Myeloma http://t.co/zG2MO7aI

Understanding a Multiple Myeloma Diagnosis - Patient Power

patientpower.info — “What is myeloma? What does a myeloma diagnosis mean for you? In this video, Dr. Noopur Raje explains myeloma’s effect on the body, blood and bones. Dr. Bill Bensinger joins Dr. Raje to explore the different types of myeloma—including MGUS and smoldering myeloma—and discusses developing research into whether or not early treatment at an asymptomatic phase of the disease is beneficial.” View full resource at patientpower.info

Most Recently Shared on February 29, 2012 at 4:24 pm By:

Andrew Schorr Support

Understanding a Multiple Myeloma Diagnosis - Patient Power - http://t.co/LdjSitJP

Treatment Strategies Medical Publisher

Treatment Strategies - Hematology - Volume 2 Issue 1

viewer.zmags.com — “Treatment Strategies - Hematology - Volume 2 Issue 1” View full resource at viewer.zmags.com

Most Recently Shared on February 24, 2012 at 1:50 pm By:

Read Charlotte Pawlyn's article on Multiple Myeloma from #ASH2011 http://t.co/xQYZ5qiO #treatmentstrategies

A Monoclonal Antibody for Multiple Myeloma - Patient Power

patientpower.info — “Dr. Robert Orlowski, from MD Anderson, explains the basics of elotuzumab.” View full resource at patientpower.info

Most Recently Shared on February 20, 2012 at 6:55 pm By:

Andrew Schorr Support

A Monoclonal Antibody for Multiple Myeloma - Patient Power - http://t.co/IIAVdoEg